Log In
Print this Print this

recilisib sodium (Subcutaneous Ex-RAD) (ON 01210.Na)

  Manage Alerts
Collapse Summary General Information
Company Onconova Therapeutics Inc.
DescriptionSubcutaneous formulation of a synthetic, low molecular weight radioprotectant that modulates DNA repair pathways
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPoisoning
Indication DetailsTreat and prevent acute radiation syndrome (ARS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today